Traditional methods using the RBC indices and Hb analysis, either by HPLC or CE, as primary screenings for thalassemia are limited because some silent thalassemia carriers with normal or borderline red cell indices/HbA2 levels may not be detected or can be missed, even in patients with combined carriers of α- and β-thalassemia. This evidence concerns the gene HBA2 and thalassemia.